Skip to main content

Articles Tagged With: COVID-19

  • Community-Acquired Pneumonia in the Era of COVID-19

    Community-acquired pneumonia is a leading infectious cause of hospitalization and mortality, with increased prevalence during the current COVID-19 pandemic. It is important to focus on appropriate testing, prompt treatment, and disposition to improve outcomes and maximize efficient use of limited resources during this global pandemic.

  • ACC Publishes Guidance on Managing Cardiovascular Ailments Post-COVID Infection

    Expert panel created document to help clinicians manage patients with myocarditis and other long COVID problems associated with SARS-CoV-2.

  • Prevalence of Acute Myocarditis Related to COVID-19 Vaccination and SARS-CoV-2

    Acute myocarditis is a diagnosis that has had a significant rise in prevalence and is the center of many recent discussions in the medical literature. Much of this recent increase has been secondary to SARS-CoV-2 and the COVID-19 vaccines. Amid the global SARS-CoV-2 pandemic, acute myocarditis has become much more prevalent in patients where it was previously a rare pathology. As a result of this outbreak, it has become a disease entity necessitating new and ever evolving clinical guidelines.

  • OSHA Announces COVID Inspections in Hospitals, SNFs

    The Occupational Safety and Health Administration has announced a temporary increase in “focused” inspections of hospitals and skilled nursing facilities that treat or handle COVID-19 patients.

  • Your Brain on COVID: Damage Found in Two New Studies

    Dementia and other adverse effects on the brain are occurring in some COVID-19 survivors, an ominous finding for the millions infected even those with only mild symptoms, according to two new studies.

  • Misinformation Continues to Undermine Pandemic Response

    Misinformation and outright lies have swept the globe during the last two years, undermining the pandemic response in hospitals and communities. In a recent call to action report, the Association for Professionals in Infection Control and Epidemiology warned infection preventionists this phenomenon has been harmful and no doubt will occur during the next pandemic.

  • APIC Asks Feds for Infection Prevention Reinforcements

    The leading organization for infection preventionists is trying to elevate and solidify their role in healthcare after many were dislodged from traditional duties or otherwise overwhelmed during the pandemic. The Association for Professionals in Infection Control and Epidemiology has issued a call to action report, which describes IPs as key players in pandemics and emergency response, as well as the longstanding wall between vulnerable patients and healthcare infections.

  • Mind the Gap: A Wary Shift from Pandemic to Endemic

    As COVID-19 cases drop dramatically and public health officials relax masking guidelines based on the local situation, there is the temptation to assume the pandemic is over and is entering a broadly defined endemic phase.

  • DOJ Report on FCA Settlements Shows Focus on Healthcare

    The U.S. Department of Justice recently announced it recovered more than $5.6 billion under the False Claims Act in fiscal year 2021, more than double the $2.3 billion recovered in fiscal year 2020. Healthcare-related recoveries accounted for almost 90% of the 2021 settlements and judgments.
  • Drug Diversion Creates Significant Liability Risk

    Drug diversion is a perennial problem for healthcare organizations. Risk managers should know there is substantial liability risk from the possible effects on patient safety. This problem is not improving, industry sources say — and some things are getting worse.